A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations

Villaruz, LC; Wang, X; Bertino, EM; Gu, L; Antonia, SJ; Burns, TF; Clarke, J; Crawford, J; Evans, TL; Friedland, DM; Otterson, GA; Ready, NE; Wozniak, AJ; Stinchcombe, TE

Stinchcombe, TE (通讯作者)，Duke Canc Inst, DUMC 3198, 25178 Morris Bldg, Durham, NC 27710 USA.

ESMO OPEN, 2023; 8 (2):

Abstract

Background: For patients with stage IV non-small-cell lung cancer with epidermal growth factor receptor (EGFR) exon 19 deletions and exon 21 L858R mut......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索